Literature DB >> 11513953

Gene structure, chromosomal localization and analysis of 3-ketosteroid reductase activity of the human 3(alpha-->beta)-hydroxysteroid epimerase.

X F Huang1, V Luu-The.   

Abstract

Following our previous characterization of the first human 3(alpha-->beta)hydroxysteroid epimerase (hHSE), we determined the genomic structure and chromosomal localization of the hHSE gene using fluorescent in situ hybridization (FISH) in this study. The gene spans 23 kb and contains five exons and four introns. FISH mapping assigned this gene to chromosome band 12q13. Primer extension analysis allowed the identification of a single transcription start site at 179 bp upstream from the ATG start codon. The 5'-flanking sequence lacks a typical TATA box in the proximal region of the transcription start site. However, analysis of the 2 kb promoter region revealed the presence of multiple potential transcription factor binding sites. Furthermore, we studied the 3-ketosteroid reductase activity demonstrated by hHSE in intact cells stably expressing the enzyme. It has been known that, in vitro, 3beta-hydroxysteroid dehydrogenase (3beta-HSD) shows both oxidative and reductive activity. Our results showed that hHSE catalyzes the reduction of 3-ketosteroids to form 3beta-hydroxysteroids while 3beta-HSD cannot catalyze this reaction in intact cells. However, hHSE showed 3-keto reductase activity in both microsomal fractions and intact cells. Since intact cells constitute a system which closely reflects in vivo intracellular conditions, we propose that hHSE might contribute to the cellular 3-ketosteroid reductase activity in the peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513953     DOI: 10.1016/s0167-4781(01)00247-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer.

Authors:  Selvaraj Muthusamy; Stefan Andersson; Hyun-Jin Kim; Ryan Butler; Linda Waage; Ulf Bergerheim; Jan-Åke Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-23       Impact factor: 11.205

2.  HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma.

Authors:  Tian Tian; Fu Hong; Zhiwen Wang; Jiaru Hu; Ni Chen; Lei Lv; Qiyi Yi
Journal:  Cell Death Discov       Date:  2021-11-08

3.  Comparative Proteomic Analysis of Liver Tissues and Serum in db/db Mice.

Authors:  Yu Zhang; Xiumei Wu; Mengyun Xu; Tong Yue; Ping Ling; Tingyu Fang; Sihui Luo; Suowen Xu; Jianping Weng
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

4.  Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma.

Authors:  Lei Lv; Yujia Zhao; Qinqin Wei; Ye Zhao; Qiyi Yi
Journal:  Cancer Cell Int       Date:  2020-06-03       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.